Well Referenced

Tag: Viscum album L

Safety of higher dosages of Viscum album L. in animals and humans—systematic review of immune changes and safety parameters

This systematic review analyzed 69 studies (22 animal and 47 human) to assess the safety and immunological effects of high-dose Viscum album L. (European mistletoe) extracts. In animal studies, doses up to 1400 mg/kg were administered without lethal outcomes, though some reversible adverse effects were noted. Human studies involved doses

Read More »
June 26, 2025 No Comments

Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis

This multicenter observational study evaluated the impact of adding Viscum album L. (European mistletoe) extract to standard chemotherapy in 158 patients with stage IV non-small cell lung cancer (NSCLC). Patients were divided into two groups: 108 received chemotherapy alone, while 50 received chemotherapy plus Viscum album L. The median overall

Read More »
June 26, 2025 No Comments

Analysis of Changes in Cancer-Related Fatigue of Breast Cancer Patients Receiving an Integrative Medicine Program

This observational study evaluated the impact of an integrative medicine program on cancer-related fatigue (CRF) in breast cancer patients. The program included non-pharmacological interventions (NPIs) such as nursing compresses, elaborate consultations and life review (ECLR), exercise therapy, and Viscum album L. extracts. Results showed that chemotherapy worsened CRF, but NPIs,

Read More »
June 26, 2025 No Comments